fromIPWatchdog.com | Patents & Intellectual Property Law
22 hours agoCAFC Upholds Win for Janssen on Patent for Antipsychotic Med Dosing Regimen
The U.S. Court of Appeals for the Federal Circuit affirmed that Teva Pharmaceuticals did not prove the claims of Janssen Pharmaceuticals' patent for antipsychotic dosing regimens invalid for obviousness.
Law